2025 second_quarter Filing

Income

$60K

Filed

July 21, 2025

Lobbying Activities

Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041; Affordable Prescriptions for Patients Act.

Contacted:HOUSE OF REPRESENTATIVES, SENATE

Trade (domestic/foreign)View all

Issues related to tariff and trade policy.

Contacted:HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE

PharmacyView all

Issues related to prescription drug value, including H.R. 1, FY25 budget reconciliation, implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. H.R. 1492, to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including H.R.1 - One Big Beautiful Bill Act. Issues related to the 340B program.

Lobbyists (2)

HAZEN CLAY MARSHALL

Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles

MONICA POPP

Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint